Apimeds Pharmaceuticals US, Inc. APUS
2.73 USD -0.19 (-6.51%)
At closeNov 5, 2026, 4:00 PM EST
2.96 +0.23 +8.42%
After hours · Nov 5, 4:00 PM ET
2.60 Day range 2.88
1.51 52-week range 59.70
- YTD
- -83.35%
- 1 year
- -90.04%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -11.91M | -1.28M | -747.44K | -639.53K | |
| -6.00M | -1.39M | -777.69K | -668.67K | |
| -5.50 | -1.80 | -1.70 | -1.82 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 9.64M | 3.46K | 410.48K | 6.17K | |
| 164.18M | 13.06K | 422.08K | 6.17K | |
| 10.84M | 1.37M | 390.21K | 719.78K | |
| 7.77M | 673.34K | 266.89K | 682.90K | |
| 153.35M | -1.36M | 31.87K | -713.61K |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -8.93M | -733.53K | -627.79K | -448.17K | |
| -10.06M | 0 | 0 | 0 | |
| 20.62M | 326.50K | 1.03M | 282.90K | |
| -75.70K | 0 | 0 | 0 | |
| 1.63M | -407.03K | 404.31K | -165.27K |